Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Bibliographic Details
Main Authors:	Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide
by: Jing-Jing Du, et al.
Published: (2022-02-01)

Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion
by: Mario Cano-Muñoz, et al.
Published: (2022-03-01)

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
by: Giemza E, et al.
Published: (2009-10-01)

Pepetela: O cronista pós-comunista do MPLA
by: Rothwell, P
Published: (2020)

The international and domestic fabrics of an ideological illusion: the Socialist MPLA
by: Nuno de Fragoso Vidal
Published: (2021-11-01)

Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity
by: Mario Cano-Muñoz, et al.
Published: (2021-04-01)

P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
by: Devillers G, et al.
Published: (2009-10-01)

Development of HIV-1 fusion inhibitors targeting gp41
by: Lu, K., et al.
Published: (2014)

Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC
by: Paulina A. García-González, et al.
Published: (2019-05-01)

Solid-state NMR investigation of viral fusion glycoprotein 41 (gp41)
by: Morgan, Chloe A.(Chloe Anne)
Published: (2020)

O MPLA e a governação: entre internacionalismo progressista marxista e pragmatismo liberal-nacionalista = MPLA and government: between marxist progressive-internationalism and liberal nationalist-pragmatism = El MPLA y el gobierno: entre el internacionalismo progresista marxista y el pragmatismo liberal-nacionalista
by: Vidal, Nuno Carlos de Fragoso
Published: (2016-01-01)

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
by: Jennifer Zimmermann, et al.
Published: (2022-08-01)

SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41
by: Moore, J, et al.
Published: (1991)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
by: Sahar Tahaghoghi-Hajghorbani, et al.
Published: (2023-04-01)

Neutralizing Antibodies Targeting HIV-1 gp41
by: Christophe Caillat, et al.
Published: (2020-10-01)

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.
by: Yates, N, et al.
Published: (2013)

P12-08. Membrane-specific antibodies that simultaneously bind to gp41 of HIV-1 and membrane lipid epitopes are induced by immunization with liposomes
by: Alving CR, et al.
Published: (2009-10-01)

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
by: Moog C, et al.
Published: (2012-09-01)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
by: Sharma SK, et al.
Published: (2012-09-01)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
by: Caffrey Michael, et al.
Published: (2004-03-01)

Antiviral properties of two trimeric recombinant gp41 proteins
by: Nisole Sébastien, et al.
Published: (2006-03-01)

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
by: Mann JF, et al.
Published: (2012-09-01)

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status
by: Olivier Lucar, et al.
Published: (2017-08-01)

Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
by: Catherine A Blish, et al.
Published: (2008-01-01)

Liposome-mediated cellular delivery of active gp91(phox).
by: Bruno Marques, et al.
Published: (2007-01-01)

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01)

Deolinda Rodrigues, da Família Metodista à Família MPLA, o Papel da Cultura na Política
by: Margarida Paredes
Published: (2010-12-01)

CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.
by: Antoine Roquilly, et al.
Published: (2010-01-01)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
by: Nika M. Strokappe, et al.
Published: (2019-06-01)

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.
by: Sattentau, Q, et al.
Published: (1995)

Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model
by: Wegmann, F, et al.
Published: (2007)

Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies?
by: Scherer, E, et al.
Published: (2008)

HIV entry : a biophysical and mutational analysis of gp41-mediated membrane fusion and its inhibition
by: Suntoke, Tara R
Published: (2006)

Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
by: Mei-Yun Zhang, et al.
Published: (2012-01-01)

Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.
by: Ryan B Craig, et al.
Published: (2012-01-01)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
by: Constantinos Kurt Wibmer, et al.
Published: (2017-01-01)

Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein
by: Garry Robert F, et al.
Published: (2007-11-01)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

DNA unwinding by ring-shaped T4 helicase gp41 is hindered by tension on the occluded strand.
by: Noah Ribeck, et al.
Published: (2013-01-01)